Myriad Genetics | MYGN - Assets


Myriad Genetics reported $728.1M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agilent USD 12.73B 501M Sep/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Bruker USD 6.24B 193.5M Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Exact Sciences USD 5.86B 39.38M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
Illumina USD 6.64B 467M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Mettler Toledo International USD 3.71B 191.18M Dec/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
OraSure Technologies USD 423.1M 21.94M Sep/2025
Pacific Biosciences Of California USD 803.16M 22.31M Sep/2025
Quest Diagnostics USD 16.23B 28M Dec/2025
Quidel USD 5.77B 94.2M Dec/2025
Repligen USD 2.95B 25.99M Dec/2025
Revvity USD 12.17B 29.46M Dec/2025
Standard Biotools USD 539.64M 17.32M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Veracyte USD 1.37B 23.68M Sep/2025
Waters USD 5.08B 221.41M Dec/2025